Causes and predictors of treatment failures in patients with ICU-acquired pneumonia

M. Ioanas, R. Ferrer, M. Ferrer, S. Ewig, J. Angrill, A. Rano, A. de Roux, C. Agusti, P. de la Bellacasa, A. Torres (Bucharest, Romania; Sabadell, Barcelona, Spain; Bonn, Germany)

Source: Annual Congress 2002 - Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU
Session: Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU
Session type: Oral Presentation
Number: 234
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ioanas, R. Ferrer, M. Ferrer, S. Ewig, J. Angrill, A. Rano, A. de Roux, C. Agusti, P. de la Bellacasa, A. Torres (Bucharest, Romania; Sabadell, Barcelona, Spain; Bonn, Germany). Causes and predictors of treatment failures in patients with ICU-acquired pneumonia. Eur Respir J 2002; 20: Suppl. 38, 234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
Source: Eur Respir J, 56 (3) 2002961; 10.1183/13993003.02961-2020
Year: 2020



Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
Source: Eur Respir J, 56 (3) 2002439; 10.1183/13993003.02439-2020
Year: 2020



Biomarkers as complication predictors in community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009



Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




Predictors of rehospitalization after admission for community-acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007

Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Validation of treatment failure criteria of nosocomial pneumonia in ICU
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011


On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021